Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 77034

Sort by

Sort Order Select

Journal Articles

Microenvironmental cell interactions are essential for sustaining functionality of myelofibrosis malignant stem cells

Min Lu, Md. Babu Mia, Lijuan Xia, Gohar Mosoyan, Momina Hayat, Christoph Schaniel, Ronald Hoffman

Blood blood.2025031454.

https://doi.org/10.1182/blood.2025031454

Published: 2025

Includes: Supplemental data

Journal Articles

Risk of bleeding in chronic lymphocytic leukemia patients in remission treated with covalent Bruton tyrosine kinase inhibitors and contemporary anticoagulant or antiplatelet drugs: Real-world data analysis

Vladimir Otasevic, Darko Antic, Kausik Maiti MD, Heidi Cho, Nancy Lunney, Darko Dabic, Chris Learn

Blood (2025) 146 (Supplement 1): 6315.

https://doi.org/10.1182/blood-2025-6315

Published: 2025

Journal Articles

Administration of off-the-shelf, expanded, most closely HLA matched, third party viral specific T cells for the therapy of adenovirus related disease in adult immunocompromised patients.

Blood (2025) 146 (Supplement 1): 5951.

https://doi.org/10.1182/blood-2025-5951

Published: 2025

Journal Articles

Hematologic predictors of serious infection and impact of serious infection on long-term mortality in AML patients: Insights from propensity-matched real-world cohorts

Dikshya Shrestha, Nancy Lunney, Kausik Maiti MD

Blood (2025) 146 (Supplement 1): 2849.

https://doi.org/10.1182/blood-2025-2849

Published: 2025

Journal Articles

Real-world AML survival paradox: Early escalation vs. sustained remission

Maria Ahmad, Kausik Maiti MD, Heidi Cho, Vladimir Otasevic, Nancy Lunney

Blood (2025) 146 (Supplement 1): 8159.

https://doi.org/10.1182/blood-2025-8159

Published: 2025

Journal Articles

Incidence and risk factors of hemophagocytic lymphohistiocytosis after bispecific antibody therapy in hematologic malignancies: Insights from a global real-world cohort

Kausik Maiti MD, Maria Ahmad, Nancy Lunney

Blood (2025) 146 (Supplement 1): 4763.

https://doi.org/10.1182/blood-2025-4763

Published: 2025

Journal Articles

Comparative analysis of severe infection risk and survival outcomes in DLBCL patients treated with CAR T-cell therapy versus standard chemoimmunotherapy: Insights from real-world data

Nancy Lunney, Kausik Maiti MD, Chris Learn, Heidi Cho

Blood (2025) 146 (Supplement 1): 8032.

https://doi.org/10.1182/blood-2025-8032

Published: 2025

Journal Articles

Dual targeting of ROR1 and ROR2 with glycoengineered antibodies elicits potent and selective immunotherapy in hairy cell leukemia

Md Kamrul Hasan, George Widhopf, Thomas Kipps

Blood (2025) 146 (Supplement 1): 2359.

https://doi.org/10.1182/blood-2025-2359

Published: 2025

Journal Articles

PSMD3 orchestrates metabolic reprogramming and immunogenic cell death in multiple myeloma

Teng Fang, Ting Du, Arghya Ray, Xueping Wan, Minxing Wang, Sindhu Pillai, Md Abu Musa, Filip Garbicz, Kenneth Wen, Mu Hao, Lugui Qiu, Yan Song, Kenneth Anderson

Blood (2025) 146 (Supplement 1): 3926.

https://doi.org/10.1182/blood-2025-3926

Published: 2025

Journal Articles

Single cell transcriptional profiling reveals distinct subsets of human megakaryocytes in myelofibrosis

MD Babu Mia, Lilian Varricchio, Ronald Hoffman

Blood (2025) 146 (Supplement 1): 3017.

https://doi.org/10.1182/blood-2025-3017

Published: 2025

Journal Articles

Myelofibrosis stem cell fitness requires microenvironmental cell interactions

Min Lu, MD Babu Mia, Lijuan Xia, Gohar Mosoyan, Momina Hayat, Christoph Schaniel, Ronald Hoffman

Blood (2025) 146 (Supplement 1): 1981.

https://doi.org/10.1182/blood-2025-1981

Published: 2025

Journal Articles

First-in-human phase 1 trial of trimeric APRIL (TriPRIL) CAR T cells in relapsed or refractory multiple myeloma: Clinical outcomes and biological correlates of disease response and resistance

Blood (2025) 146 (Supplement 1): 270.

https://doi.org/10.1182/blood-2025-270

Published: 2025

Journal Articles

The unique role of PSMD2/Rpn1 among ubiquitin receptors in multiple myeloma highlights its potential as a therapeutic target to overcome proteasome inhibitor resistance

Ting Du, Yuntong Liu, Minxing Wang, Teng Fang, Jingyu Xu, Kenneth Wen, Xueping Wan, Arghya Ray, Sindhu Pillai, Md Abu Musa, Mariateresa Fulciniti, Nikhil Munshi, Yan Song, Kenneth Anderson

Blood (2025) 146 (Supplement 1): 2148.

https://doi.org/10.1182/blood-2025-2148

Published: 2025

Journal Articles

High-affinity PD-1-CD28 switch receptor enhances sustained antitumor activity of CAR-T cells in both lymphoma and ewing sarcoma.

Hanzhi Du, MD, Helong Gong, Yidan Wang, Zihang Li, PhD, Kaijing Chang, Sirui Duan, Qiuyi Ma, Huachao Zhu, Di Wu, MD, Stefan Burdach, MD, PhD, Jürgen Ruland, MD, PhD, Pengcheng He, MD, PhD, Busheng Xue, MD

Blood (2025) 146 (Supplement 1): 4102.

https://doi.org/10.1182/blood-2025-4102

Published: 2025

Journal Articles

Safety and efficacy of carniospinal irradiation (CSI) before CAR T cell therapy in patients with acute lymphoblastic leukemia (ALL) with central nervous system (CNS) disease: A potential role for CSI beyond cell killing and into immune priming

Blood (2025) 146 (Supplement 1): 3326.

https://doi.org/10.1182/blood-2025-3326

Published: 2025

Journal Articles

Using a magnetic column separator to determine the magnetophoretic behavior and adhesion characteristics of oxygenated sickle and healthy red blood cells

Poornima Iyer, Hyeon Choe, Md Majidur Rahman, Jacob Strayer, Xian Wu, Kristina Landes, Jacob Doon-Ralls, Betul Karakuzu, Jenifer Gomez-Pastora, Andre Palmer, Maciej Zborowski, Payal Desai, Jeffrey Chalmers

Blood (2025) 146 (Supplement 1): 1189.

https://doi.org/10.1182/blood-2025-1189

Published: 2025

Journal Articles

Cyclophosphamide versus methotrexate for treating large granular lymphocyte leukemia: Real-world data insights

Vladimir Otasevic, Heidi Cho, Darko Antic, Kausik Maiti MD, Nancy Lunney, Darko Dabic, Chris Learn

Blood (2025) 146 (Supplement 1): 4490.

https://doi.org/10.1182/blood-2025-4490

Published: 2025

Journal Articles

Prevalence and significance of cytoses in clonal hematpoiesis

Virginia Volpe, Keishla Arce-Ruiz, Yating Wang, Caitlyn Vlasschaert, Md Mesbah Uddin, Pradeep Natarajan, Daniel Deangelo, Alexander Bick, Marlise Luskin, R. Coleman Lindsley, Shai Shimony, Lachelle Weeks

Blood (2025) 146 (Supplement 1): 1387.

https://doi.org/10.1182/blood-2025-1387

Published: 2025

Journal Articles

A pre-NGS screening strategy to identify populations with high-risk clonal hematopoiesis

Riya Nandi, Caitlyn Vlasschaert, Md Mesbah Uddin, Pradeep Natarajan, Daniel Deangelo, Marlise Luskin, R. Coleman Lindsley, Alexander Bick, Shai Shimony, Lachelle Weeks

Blood (2025) 146 (Supplement 1): 1386.

https://doi.org/10.1182/blood-2025-1386

Published: 2025

Journal Articles

Lentiviral vectors engineered for direct In Vivo delivery to resting T cells

Blood (2025) 146 (Supplement 1): 5902.

https://doi.org/10.1182/blood-2025-5902

Published: 2025

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Microenvironmental cell interactions are essential for sustaining functionality of myelofibrosis malignant stem cells

Risk of bleeding in chronic lymphocytic leukemia patients in remission treated with covalent Bruton tyrosine kinase inhibitors and contemporary anticoagulant or antiplatelet drugs: Real-world data analysis

Administration of off-the-shelf, expanded, most closely HLA matched, third party viral specific T cells for the therapy of adenovirus related disease in adult immunocompromised patients.

Hematologic predictors of serious infection and impact of serious infection on long-term mortality in AML patients: Insights from propensity-matched real-world cohorts

Real-world AML survival paradox: Early escalation vs. sustained remission

Incidence and risk factors of hemophagocytic lymphohistiocytosis after bispecific antibody therapy in hematologic malignancies: Insights from a global real-world cohort

Comparative analysis of severe infection risk and survival outcomes in DLBCL patients treated with CAR T-cell therapy versus standard chemoimmunotherapy: Insights from real-world data

Dual targeting of ROR1 and ROR2 with glycoengineered antibodies elicits potent and selective immunotherapy in hairy cell leukemia

PSMD3 orchestrates metabolic reprogramming and immunogenic cell death in multiple myeloma

Single cell transcriptional profiling reveals distinct subsets of human megakaryocytes in myelofibrosis

Myelofibrosis stem cell fitness requires microenvironmental cell interactions

First-in-human phase 1 trial of trimeric APRIL (TriPRIL) CAR T cells in relapsed or refractory multiple myeloma: Clinical outcomes and biological correlates of disease response and resistance

The unique role of PSMD2/Rpn1 among ubiquitin receptors in multiple myeloma highlights its potential as a therapeutic target to overcome proteasome inhibitor resistance

High-affinity PD-1-CD28 switch receptor enhances sustained antitumor activity of CAR-T cells in both lymphoma and ewing sarcoma.

Safety and efficacy of carniospinal irradiation (CSI) before CAR T cell therapy in patients with acute lymphoblastic leukemia (ALL) with central nervous system (CNS) disease: A potential role for CSI beyond cell killing and into immune priming

Using a magnetic column separator to determine the magnetophoretic behavior and adhesion characteristics of oxygenated sickle and healthy red blood cells

Cyclophosphamide versus methotrexate for treating large granular lymphocyte leukemia: Real-world data insights

Prevalence and significance of cytoses in clonal hematpoiesis

A pre-NGS screening strategy to identify populations with high-risk clonal hematopoiesis

Lentiviral vectors engineered for direct In Vivo delivery to resting T cells

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only